Genetic modifiers of synucleinopathies-lessons from experimental models
- PMID: 38596238
- PMCID: PMC10913850
- DOI: 10.1093/oons/kvad001
Genetic modifiers of synucleinopathies-lessons from experimental models
Abstract
α-Synuclein is a pleiotropic protein underlying a group of progressive neurodegenerative diseases, including Parkinson's disease and dementia with Lewy bodies. Together, these are known as synucleinopathies. Like all neurological diseases, understanding of disease mechanisms is hampered by the lack of access to biopsy tissues, precluding a real-time view of disease progression in the human body. This has driven researchers to devise various experimental models ranging from yeast to flies to human brain organoids, aiming to recapitulate aspects of synucleinopathies. Studies of these models have uncovered numerous genetic modifiers of α-synuclein, most of which are evolutionarily conserved. This review discusses what we have learned about disease mechanisms from these modifiers, and ways in which the study of modifiers have supported ongoing efforts to engineer disease-modifying interventions for synucleinopathies.
Keywords: Drug targets; Genetic modifiers; Lewy bodies; Parkinson’s disease; SNCA; α-synuclein.
© The Author(s) 2023. Published by Oxford University Press.
Conflict of interest statement
Both authors have no conflict of interest to declare.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10913850/bin/kvad001f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10913850/bin/kvad001f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10913850/bin/kvad001f3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10913850/bin/kvad001f4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10913850/bin/kvad001f5.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10913850/bin/kvad001f6.gif)
![Figure 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10913850/bin/kvad001f7.gif)
Similar articles
-
Neuropathology and molecular diagnosis of Synucleinopathies.Mol Neurodegener. 2021 Dec 18;16(1):83. doi: 10.1186/s13024-021-00501-z. Mol Neurodegener. 2021. PMID: 34922583 Free PMC article. Review.
-
Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy.Brain Commun. 2021 Sep 25;3(4):fcab223. doi: 10.1093/braincomms/fcab223. eCollection 2021. Brain Commun. 2021. PMID: 34632384 Free PMC article.
-
Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies.Int J Mol Sci. 2022 Jun 1;23(11):6216. doi: 10.3390/ijms23116216. Int J Mol Sci. 2022. PMID: 35682892 Free PMC article. Review.
-
Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy.Acta Neuropathol Commun. 2020 Aug 28;8(1):150. doi: 10.1186/s40478-020-01026-0. Acta Neuropathol Commun. 2020. PMID: 32859276 Free PMC article.
-
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.Lancet Neurol. 2011 Mar;10(3):230-40. doi: 10.1016/S1474-4422(11)70014-X. Lancet Neurol. 2011. PMID: 21317042
References
-
- Goedert M, Spillantini MG, Del Tredici Ket al. . 100 years of Lewy pathology. Nat Rev Neurol 2013;9:13–24 - PubMed
-
- Spillantini , Schmidt ML, Lee VM-Yet al. . α-Synuclein in Lewy bodies. Nature 1997;388:839–40 - PubMed
-
- Spillantini , Crowther RA, Jakes Ret al. . Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodies. Neurosci Lett 1998;251:205–8 - PubMed
-
- Tu PH, Galvin JE, Baba Met al. . Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 1998;44:415–22 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous